Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 301–400 of 553
Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases
Varshney, V., Gabble, B. C., Bishoyi, A. K., Varma, P., Qahtan, S. A., Kashyap, A., Panigrahi, R., Nathiya, D., & Chauhan, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05026-w · Cited by 14
Bukke, S. P. N., Yadav, S., Prajapati, S., Rani, S. S., Reddy, M. S., Thalluri, C., Chettupalli, A. K., Goruntla, N., Pradeepkumar, B., Eftekhari, Z., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2607157 · Cited by 13
Balzano, T., Esteban-García, N., & Blesa, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2160440 · Cited by 13
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Ferreira, S. A., Li, C., Klæstrup, I. H., Vitic, Z., Rasmussen, R. K., Kirkegaard, A., Toft, G. U., Betzer, C., Svendsen, P., Jensen, P. H., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00606-w · Cited by 13
Schweigmann, M., Caudal, L. C., Stopper, G., Scheller, A., Koch, K. P., & Kirchhoff, F. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.720675 · Cited by 13
Li, N., Huang, Y., Wu, Y., Wang, Q., & Ji, P. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137562 · Cited by 11
Anwar, M. M., Pérez‐Martínez, L., & Pedraza‐Alva, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2358446 · Cited by 11
Yu, S., Cheng, Q., Yu, Q., Cui, Z., Chen, H., Wu, S., Jin, Y., Wang, Y., Li, M., & Lu, Z. (2026) · Aging Cell · doi:10.1111/acel.70350 · Cited by 13
Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases
Hu, C., Yan, Y., Jin, Y., Yang, J., Xi, Y., & Zhong, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01115-9 · Cited by 12
The Neuromuscular Disorder Mediated by Extracellular Vesicles in Amyotrophic Lateral Sclerosis
Carata, E., Muci, M., Giulio, S. D., Giulio, T. D., Mariano, S., & Panzarini, E. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060358 · Cited by 11
Francesco, V. D., Chua, A. J. K., Bleier, B. S., & Amiji, M. M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c18679 · Cited by 11
Torrente, D., Su, E. J., Citalán‐Madrid, A. F., Schielke, G. P., Magaoay, D., Warnock, M., Stevenson, T. K., Mann, K. M., Lesept, F., Delétage, N., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03336-3 · Cited by 11
Regulatory Roles of Exosomes in Aging and Aging-Related Diseases
Xiao, N., Li, Q., Liang, G., Qian, Z., Lin, Y., Zhang, H., Fu, Y., Yang, X. M., Zhang, C., Yang, J., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10200-7 · Cited by 10
Li, F., Wu, L., Feng, X., Li, Y., & Fan, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010070 · Cited by 11
An, W., Jin, Z., & Li, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1708655 · Cited by 12
Two roads diverged in a cell: insights from differential exosome regulation in polarized cells
Komori, T., & Fukuda, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1451988 · Cited by 10
Akbari‐Gharalari, N., Ghahremani‐Nasab, M., Naderi, R., Chodari, L., & Nezhadshahmohammad, F. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024023 · Cited by 10
Zhao, X., Cao, R., Tian, X., Liu, P., Liu, D., Yu, X., Zheng, Z., Chen, G., & Zou, L. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04388-w · Cited by 11
Hirschberg, Y., Boonen, K., Schildermans, K., van Dam, A., Pintelon, I., Vandendriessche, C., Velimirović, M., Jacobs, A., Vandenbroucke, R. E., Nelissen, I., et al. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.55 · Cited by 10
The indispensability of macrophage adaptor proteins in chronic inflammatory diseases
Atre, R., Sharma, R., Gaponenko, V., Solanki, K., Wadhonkar, K., Singh, N., Patidar, P., Khabiya, R., Samaur, H., Banerjee, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110176 · Cited by 10
An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis
Wang, K., Shen, J., & Xu, Y. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.017 · Cited by 10
Luo, H., Chen, J. M., Liu, J., Wang, W., Hou, C., Jiang, X., Ma, J., Xu, F., Aili, X., Zhou, Z., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1479272 · Cited by 9
Exosomes and Their miRNA as a Potential Biomarker in the Diagnosis of Parkinson’s Disease
Vijayakumar, S., Yesudhason, B. V., Anandharaj, J. L., Kalaivanan, L., & Christyraj, J. R. S. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00313 · Cited by 11
Chen, Y., Sun, X., Xi, Y., Luo, Z., Lai, H., Zhu, D., Zhang, Y., Xu, F., Li, J., Zhou, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.016 · Cited by 10
Xu, H., Zhang, J., & Li, M. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100530 · Cited by 18
The dual role of microglia in neurodegenerative diseases: A review
Zhang, N., Xiong, N., He, Y., & Zhou, L. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111887 · Cited by 9
The Biology, Pathological Roles of Exosomes and Their Clinical Application in Parkinson’s Disease
Huang, J., Yuan, X., Chen, L., Hu, B., Wang, H., & Huang, W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.09.001 · Cited by 9
The intestinal luminal sources of α-synuclein: a gastroenterologist perspective
Lerner, A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab024 · Cited by 9
Franck, L., Hahnefeld, L., Valek, L., Klatt‐Schreiner, K., Wilken‐Schmitz, A., Alnouri, M. W., Trautmann, S., Weyer, M.-P., Thomas, D., Gurke, R., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01114-9 · Cited by 8
Quantum dot-based nanodiagnostics for neurodegenerative disorders advances and future perspectives
Pınar, Z. N., Özkan, M., & Ihlamur, M. (2025) · Next research. · doi:10.1016/j.nexres.2025.101024 · Cited by 8
Zhang, M., You, T., Guo, M., Zhao, Y., Shen, W., Wang, Y., Jiang, Y., Dong, Q., Yu, J., Cui, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03838-5 · Cited by 9
Self-citationKamra, K., Lalam, S. K., Srivastava, S., Arumugam, M. K., Boopathy, L. K., Takkar, S., Xia, Z., & Subramanian, S. P. (2026) · Health Science Reports · doi:10.1002/hsr2.72638 · Cited by 10
Exploring the Connectivity of Neurodegenerative Diseases: Microglia as the Center
Wang, Y., Cui, L., Zhao, H., He, H., Chen, L., Song, X., Liu, D., Qiu, J., & Sun, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s440377 · Cited by 8
Afzal, M., Hameed, H., Paiva‐Santos, A. C., Saleem, M., Hameed, A., & Ahmad, S. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177199 · Cited by 9
Negah, S. S., Moradi, H. R., Forouzanfar, F., Sahraian, M. A., & Faraji, M. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04344-8 · Cited by 8
Agomir-331 Suppresses Reactive Gliosis and Neuroinflammation after Traumatic Brain Injury
Wang, J., Xiao, X., He, X., He, B., Liu, C., & Teng, Z. (2023) · Cells · doi:10.3390/cells12202429 · Cited by 8
Self-citationNon-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7
Luo, Y., Zang, N., Tang, Y., Chen, H., Liu, H., Wang, L., & Xu, P. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08812-2 · Cited by 7
Tsunemi, T., Ishiguro, Y., Yoroisaka, A., Feng, D., Shimada, T., Niiyama, S., Sasazawa, Y., Ishikawa, K., Akamatsu, W., & Hattori, N. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.2350-23.2024 · Cited by 7
Molecular engines driving biogenesis, trafficking and release of exosomes: SNARE proteins
Ogungbemi, D., Shorter, S. A., Asadollahi, R., Boussios, S., & Ovsepian, S. V. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100089 · Cited by 7
Transfer of nuclear and ribosomal material from Sox10-lineage cells to neurons in the mouse brain
Mayrhofer, F., Hanson, A. M., Navedo, M. F., Xiang, Y. K., Soulika, A. M., Deng, W., & Chechneva, O. V. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221632 · Cited by 8
Lu, Y., Chiang, C., Hsu, Y., Chen, C., Chen, W., Tseng, C., Deng, L., Chen, S., & Kuan, Y. (2024) · Environmental Toxicology · doi:10.1002/tox.24168 · Cited by 7
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Fang, X., Zhou, D., Wang, X., Ma, Y., Zhong, G., Jing, S., Huang, S., & Wang, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03957-4 · Cited by 8
The role of autophagy in brain health and disease: Insights into exosome and autophagy interactions
Wang, H., Lv, C., Feng, L., Guo, J., Zhao, S., & Jiang, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38959 · Cited by 8
Page, T. D., Musi, C. A., Bakker, S. E., Jenkins, D. R., Hill, E. J., Borsello, T., Milic, I., Devitt, A., & Repici, M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02845-7 · Cited by 6
Hamdalla, R. H., Bhaskar, V. B., & Tian, C. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1710150 · Cited by 8
Cai, L., Liu, Y., Tang, S., Deng, S., Zhang, L., Wang, Y., Zhang, B., Han, B., 谢汝佳, Liao, X., et al. (2026) · Communications Biology · doi:10.1038/s42003-025-09389-7 · Cited by 6
The interplay between autophagy and unconventional secretion in neurodegeneration
Renna, M., Bonavita, R., Dixon, G., Verdicchio, L. V., & Fleming, A. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2025.12.007 · Cited by 7
Zhao, P., Li, S., Liu, Q., Peng, X.-C., Liu, L., Yang, F.-Y., Wang, C., Qian, F., & Tang, F.-R. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1726194 · Cited by 7
microRNAs profiling of small extracellular vesicles from midbrain tissue of Parkinson’s disease
Li, Z., Chen, D., Pan, R., Zhong, Y.-B., Zhong, T., & Jiao, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1090556 · Cited by 7
Arora, A., Sharma, V., Gupta, R., & Aggarwal, A. (2024) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5011 · Cited by 6
Adebayo, O. G., Ben‐Azu, B., Akpofure, E., Modo, E. U., Ndidiamaka, I. P., Enya, J. I., Udoeyop, F. A., Oritsemuelebi, B., Chidebe, E. O., Chimezie, J., et al. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100610 · Cited by 6
So, R. W. L., Amano, G., Stuart, E., Amini, A. E., Aguzzi, A., Collingridge, G. L., & Watts, J. C. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012517 · Cited by 6
Stewart, R., Hutson, K. H., & Nestorova, G. G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.09.040 · Cited by 6
Gonçalves, P. D. C., Cerqueira, E. C., Lima, V. D. A., & Follmer, C. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2196014 · Cited by 6
WITHDRAWN: Border-associated macrophages in the central nervous system
Sun, R., & Jiang, H. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109921 · Cited by 6
RetractedTsunemi, T., Ishiguro, Y., Yoroisaka, A., Feng, D., & Hattori, N. (2025) · Cells · doi:10.3390/cells14030163 · Cited by 5
Plasma proteomic profiling reveals Parkinson's disease-associated proteins: A UK Biobank study
Jiao, X., Lü, Y., Huang, Y., Chen, J., Gu, Z., Gao, X., Yuan, L., Du, B., & Bi, X. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107851 · Cited by 5
Chen, S., Feng, N., & Liu, Y. (2025) · BMC Neurology · doi:10.1186/s12883-025-04477-x · Cited by 7
Aggregation and Propagation of α‐Synuclein in Parkinson's Disease: A Bibliometric Perspective
Zhang, X., Ma, Y., Gao, G., & Wu, Q. (2025) · Brain and Behavior · doi:10.1002/brb3.71023 · Cited by 5
Extracellular vesicles in tumor microenvironment modulation and clinical diagnosis
Liu, H., Niu, D., Yu, T., Wang, Y.-H., Ran, K.-L., Liu, Y.-H., Yin, D.-C., & Zhang, C. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156339 · Cited by 5
Hou, K., An, Z., Xu, Y., Wang, J., Zhou, M., Liu, Y., Zhu, X., & Wei, J. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01247-x · Cited by 5
Self-citationGurgone, A., Cardinale, V., Tangari, M. M., Budicin, S., Comai, D., Ledda, C., Lopiano, L., Camussi, G., Zibetti, M., & Giustetto, M. (2026) · European Journal of Neurology · doi:10.1111/ene.70508 · Cited by 5
Frontiers and future perspectives of neuroimmunology
Qi, H., Duan, S., Xu, Y., & Zhang, H. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.10.002 · Cited by 6
Li, X., Luo, M., Xu, H., Jia, L., Liang, Y., Xu, Q., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1377409 · Cited by 6
Unveiling defects of secretion mechanisms in Parkinson’s disease
Filippini, F., & Galli, T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107603 · Cited by 5
Dual role of extracellular vesicles in neurodegenerative diseases
Scuteri, A., & Donzelli, E. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i12.1002 · Cited by 5
Hydrogel–exosome complexes: a novel strategy for cardiovascular regeneration
Fu, Y., Qiu, Z., Cao, Y., Jiang, M., & Cui, X. (2025) · Nanoscale · doi:10.1039/d5nr00892a · Cited by 5
Ma, Y., Zhang, X., Xu, J., Luo, R., Li, S., Su, H., Wang, Q., & Hou, L. (2025) · Antioxidants · doi:10.3390/antiox14080963 · Cited by 5
Roles of glia-derived extracellular vesicles in central nervous system diseases: an update
Sun, H., Su, X., Li, S., Mu, D., & Qu, Y. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0144 · Cited by 5
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00001-0 · Cited by 5
Yang, Z., Li, X., Li, C., Li, M., & Xie, A. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136734 · Cited by 5
Chandra, P. K., Braun, S. E., Maity, S., Castorena‐Gonzalez, J. A., Kim, H., Shaffer, J. G., Čikić, S., Rutkai, I., Fan, J., Guidry, J. J., et al. (2023) · Viruses · doi:10.3390/v15030794 · Cited by 5
Microglia-associated research in Parkinson’s disease: a bibliometric analysis
Chen, Y.-J., Xie, M.-R., Zhou, S.-Q., & Liu, F. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1657349 · Cited by 6
Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation
Vekrellis, K., Lamprokostopoulou, A., Melachroinou, K., Kokoli, M., Zingkou, E., Skarveli, M., Kolianou, A., Samiotaki, M. K., & Sotiropoulou, G. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01122-9 · Cited by 5
Tan, Z., Hu, H., Chen, H., Lin, Y., Zhou, M., Zhang, W., Xu, P., & Chen, X. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02133-6 · Cited by 4
Guo, L., Li, Q., Li, J., & Yang, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337808 · Cited by 4
Chen, L.-L., Shen, Q., Li-ping, S., Song, Y., Jia, W., Qu, L., & Xie, J. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01691-8 · Cited by 5
Naffaa, M. M., & Independent Researcher, M. V. (2026) · AIMS neuroscience · doi:10.3934/neuroscience.2026004 · Cited by 4
Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
Yan, R., Feng, H., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749278 · Cited by 5
Huang, Y., Zhong, C.-Y., Burley, G., Shi, Y., & Lin, S. (2026) · Metabolites · doi:10.3390/metabo16030148 · Cited by 5
Rapid and sensitive detection of cancer-derived small extracellular vesicles using Janus particles
Kumar, S., Sinclair, J. A., Shi, T., Chuang, H.-S., Senapati, S., & Chang, H.-C. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01632-8 · Cited by 3
Exosomes in depression: mechanistic insights, diagnostic potential, and therapeutic opportunities
Fei, W., Yang, J., & Wang, G. H. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03622-3 · Cited by 6
You, T., Wang, Y., Xu, J., Zhao, Y., Peng, S., Han, Q., Wang, X., Zhang, M., Shen, W., Guo, M., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01117-y · Cited by 4
Self-citationGenetic modifiers of synucleinopathies—lessons from experimental models
Lee, R. M. Q., & Koh, T. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad001 · Cited by 6
Xiao, L., Wang, M., Shi, Y., Huang, X., Zhang, W., Wu, Y., Deng, H., Xiong, B., Pan, W., Zhang, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113483 · Cited by 9
Işık, M., Sari, H. K., Çağlayan, M. G., Yılmaz, R., & Derkuş, B. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70090 · Cited by 4
ATP6V0A1 protects dopaminergic neurons via the autophagy–lysosomal pathway in Parkinson’s disease
Lin, Y., Tan, Z., Ye, W., Li, W., Chen, H., Lin, Y., Zhou, M., Liu, H., Liu, Q., Zhang, Z., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01420 · Cited by 4
Immunity in Parkinson's disease – The role of innate responses
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578716 · Cited by 4
PTEN: a new dawn in Parkinson’s disease treatment
Yang, X., Liu, T., & Cheng, H. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1497555 · Cited by 4
Yang, X., Wang, J., Zeng, W., Zhang, X., Yang, X., Xu, Y. S., Xu, Y. C., & Cao, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1049418 · Cited by 4
Self-citationDias, C., Ballout, N., Morla, G., Alileche, K., Santiago, C., Guerrera, I. C., Chaubet, A., Ausseil, J., & Trudel, S. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00953-1 · Cited by 4
Ghosh, S., Choudhury, S. H., Mukherjee, K., & Bhattacharyya, S. N. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_16 · Cited by 5
Microglia-derived sEV: Friend or foe in the pathogenesis of cognitive impairment
Chen, L., & Wang, W. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111287 · Cited by 3
Wang, L., Liu, R., & Wang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591469 · Cited by 9
Elvira, R., Guan, J. S., Mu, Y., Tan, E., & Zhou, Z. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118802 · Cited by 3
Marques, B. L., Lirio, P. H. C., Vicente, M. A., Unzueta‐Larrinaga, P., Urigüen, L., & Campos, A. C. (2025) · Pharmaceuticals · doi:10.3390/ph18121817 · Cited by 3
Bernal‐Vicente, B. N., Ponce, I., Ríos‐Castro, E., Moreno‐Castilla, P., & Tovar‐y‐Romo, L. B. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70350 · Cited by 3
Redl, M., Weisenburger, S., Wasilewicz, A., Grienke, U., Lehner, M. D., Bredenbröker, D., & Rollinger, J. M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1720314 · Cited by 3
Castegna, A., Laera, L., Moda, P., Miglietta, S., D’Agostino, M., Ruggiero, M., Cianciulli, A., Filannino, F. M., Porro, C., Butterfield, D. A., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08102-4 · Cited by 3
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.